No connection

Search Results

INVX

BEARISH
$28.15 Live
Innovex International, Inc. · NYSE
Target $30.33 (+7.8%)
$11.93 52W Range $29.48

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 29, 2026
Market cap
$1.93B
P/E
23.46
ROE
8.3%
Profit margin
8.5%
Debt/Equity
0.07
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
INVX exhibits strong balance sheet health with a Piotroski F-Score of 7/9 and an exceptionally low debt-to-equity ratio of 0.07. However, the stock is fundamentally overvalued, trading at $28.15 despite a Graham Number of $20.33 and a growth-based intrinsic value of $8.40. This valuation disconnect is exacerbated by a severe collapse in year-over-year earnings growth (-56.8%) and aggressive insider selling totaling over $326 million. While the 1-year price performance is strong, the combination of bearish technicals and massive insider exits suggests the stock is currently priced for perfection in a deteriorating earnings environment.

Key Strengths

Strong financial health (Piotroski F-Score 7/9)
Extremely low leverage (Debt/Equity 0.07)
High liquidity (Current Ratio 4.91)
Healthy gross margins (31.00%)
Positive short-term Q/Q revenue growth (80.22%)

Key Risks

Severe YoY earnings collapse (-56.80%)
Massive insider liquidation ($326.95M in sales)
Significant premium to intrinsic value ($8.40) and Graham Number ($20.33)
Bearish technical trend (10/100)
Poor earnings track record (only 1 of last 4 quarters beat estimates)
AI Fair Value Estimate
Based on comprehensive analysis
$19.5
-30.7% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
42
Moderate
Value
30
Future
25
Past
60
Health
95
Dividend
0
AI Verdict
Overvalued with strong balance sheet but poor growth/insider signals
Key drivers: Insider selling, Earnings growth collapse, Valuation premium, Strong liquidity
Confidence
90%
Value
30/100

Ref P/E, Graham Number $20.33, Intrinsic Value $8.40

Positives
  • P/E is lower than sector average (23.46 vs 31.09)
Watchpoints
  • Price exceeds Graham Number by ~39%
  • Price exceeds Intrinsic Value by ~236%
Future
25/100

Ref Growth rates and Technical Trend 10/100

Positives
  • Strong Q/Q revenue growth
Watchpoints
  • YoY Earnings growth -56.80%
  • Bearish technical trend
Past
60/100

Ref Historical price performance

Positives
  • Strong 1Y return (+77%)
  • Consistent revenue growth
Watchpoints
  • Negative 5Y change (-8.7%)
Health
95/100

Ref Piotroski F-Score and Debt/Equity

Positives
  • Piotroski F-Score 7/9
  • Debt/Equity 0.07
  • Current Ratio 4.91
Watchpoints
  • Altman Z-Score not provided
Dividend
0/100

Ref Yield and Payout Ratio

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • 0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$28.15
Analyst Target
$30.33
Upside/Downside
+7.8%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for INVX and closest competitors.

Updated 2026-04-28
INV
Innovex International, Inc.
Primary
5Y
-8.7%
3Y
+3.2%
1Y
+77.0%
6M
+36.1%
1M
+16.1%
1W
+5.9%
FLN
FLEX LNG Ltd.
Peer
5Y
+368.6%
3Y
+32.5%
1Y
+50.9%
6M
+31.2%
1M
+2.4%
1W
+0.4%
NES
National Energy Services Reunited Corp.
Peer
5Y
+158.3%
3Y
+158.3%
1Y
+294.7%
6M
+122.5%
1M
+12.8%
1W
+7.2%
APC
ARKO Petroleum Corp.
Peer
5Y
+4.3%
3Y
+4.3%
1Y
+4.3%
6M
+4.3%
1M
-4.1%
1W
+2.3%
DK
Delek US Holdings, Inc.
Peer
5Y
+112.9%
3Y
+110.7%
1Y
+217.7%
6M
+7.4%
1M
-10.7%
1W
+6.5%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
23.46
Forward P/E
16.19
PEG Ratio
N/A
P/B Ratio
1.84
P/S Ratio
1.97
EV/Revenue
1.86
EV/EBITDA
10.41
Market Cap
$1.93B

Profitability

Profit margins and return metrics

Profit Margin 8.52%
Operating Margin 11.56%
Gross Margin 31.0%
ROE 8.26%
ROA 5.77%

Growth

Revenue and earnings growth rates

Revenue Growth +9.1%
Earnings Growth -56.8%
Q/Q Revenue Growth +80.22%
Q/Q Earnings Growth -56.1%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.07
Low debt
Current Ratio
4.91
Strong
Quick Ratio
3.17
Excellent
Cash/Share
$3.03

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.3B
Gross Margin
28.9%
Op. Margin
11.6%
Net Margin
5.1%
Total Assets
$1.3B
Liabilities
$0.2B
Equity
$1.1B
Debt/Equity
0.20x
Operating CF
$0.1B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
83%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-04
$N/A
2026-02-23
$0.24
-20.2% surprise
2025-11-03
$0.23
-19.4% surprise
2025-08-05
$0.65
+128.7% surprise

Energy Sector Comparison

Comparing INVX against 113 companies in the Energy sector (11 bullish, 37 neutral, 65 bearish)
P/E Ratio
23.46
This Stock
vs
31.31
Sector Avg
-25.1% (Discount)
Return on Equity (ROE)
8.26%
This Stock
vs
3.03%
Sector Avg
+172.7% (Excellent)
Profit Margin
8.52%
This Stock
vs
5.63%
Sector Avg
+51.2% (Superior)
Debt to Equity
0.07
This Stock
vs
1.3
Sector Avg
-94.3% (Less Debt)
Revenue Growth
9.1%
This Stock
vs
20.28%
Sector Avg
-55.1% (Slower)
Current Ratio
4.91
This Stock
vs
2.14
Sector Avg
+129.6% (Stronger)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

FINK BENJAMIN MATTHEW
Director
Stock Award
2026-02-27
5,465 shares
LOVOI JOHN V
Director
Stock Award
2026-02-27
5,465 shares
JUPP TERENCE BARTLETT
Director
Stock Award
2026-02-27
5,465 shares
BLACK BONNIE S
Director
Stock Award
2026-02-27
5,465 shares
REDDOUT MARK
Officer
Stock Award
2026-02-27
18,975 shares
ANDERSON ADAM
Chief Executive Officer
Stock Award
2026-02-27
47,438 shares
SEDITA ANGIE
Director
Stock Award
2026-02-27
5,465 shares
REED KENDAL
Chief Financial Officer
Stock Award
2026-02-27
18,975 shares
AMBERJACK CAPITAL PARTNERS, L.P.
Beneficial Owner of more than 10% of a Class of Security
Sell
2026-02-27
6,612,500 shares · $162,609,971
INNOVEX CO-INVEST FUND, L.P.
Director and Beneficial Owner of more than 10% of a Class of Security
Sell
2026-02-27
6,612,500 shares · $162,609,971
ANDERSON ADAM
Chief Executive Officer
Sell
2026-02-24
18,837 shares · $536,854
ANDERSON ADAM
Chief Executive Officer
Sell
2026-02-23
13,241 shares · $357,507
REDDOUT MARK
Officer
Sell
2026-01-14
20,000 shares · $500,000
ANDERSON ADAM
Chief Executive Officer
Sell
2026-01-14
13,241 shares · $331,025
REDDOUT MARK
Officer
Stock Award
2025-12-15
40 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A
DEF 14A
2026-03-27

INVX filed a Definitive Proxy Statement on March 27, 2026, providing shareholders with necessary information and voting materials for the company's annual meeting.

8-K
8-K
2026-03-11
8-K
8-K
2026-02-27

Innoviva, Inc. filed an 8-K on February 27, 2026, likely to announce its full-year financial results for the preceding fiscal year.

10-K
10-K
2026-02-24

INVX filed its annual 10-K report on February 24, 2026. Due to the lack of detailed content in the provided excerpts, specific financial highlights and risk factors are unavailable.

8-K
8-K
2026-02-23

Innoviva, Inc. likely announced its fourth-quarter and full-year financial results for the 2025 fiscal year.

8-K
8-K
2025-11-10

Innoviva, Inc. filed an 8-K likely reporting its third-quarter financial results for 2025.

10-Q
10-Q
2025-11-04

INVX submitted its 10-Q filing on November 4, 2025. While the document includes a section for Risk Factors under Item 1A, no specific financial highlights or detailed risk disclosures were provided in the available excerpt.

8-K
8-K
2025-11-03

Innoviva, Inc. (INVX) filed an 8-K on November 3, 2025, likely to report its third-quarter financial results.

10-Q
10-Q
2025-08-06

INVX filed its 10-Q on August 6, 2025, which includes a section detailing the company's risk factors. No specific financial highlights or detailed risk descriptions were provided in the available excerpts.

8-K
8-K
2025-08-05

Innoviva, Inc. filed an 8-K on August 5, 2025, likely to announce its second-quarter financial results.

8-K
8-K
2025-06-05
8-K
8-K
2025-05-15
10-Q
10-Q
2025-05-07
8-K
8-K
2025-05-06
8-K
8-K
2025-04-25
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
3 analysts
Barclays
2026-03-03
Maintains
Equal-Weight Equal-Weight
Piper Sandler
2025-12-18
Maintains
Overweight Overweight
Barclays
2025-11-14
up
Underweight Equal-Weight

Past News Coverage

Recent headlines mentioning INVX from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile